Buscar
01/06/2025
Dimensions and domains to assess secondhand tobacco smoke exposure: insights from a Delphi study
Blanco-Ferreiro, A, Rey-Brandariz, J, Ahluwalia, JS, Varela-Lema, L, Galán, I, Santiago-Pérez, MI, Sureda, X, Fu, M, Schiaffino, A, López, MJ, Continente, X, Candal-Pedreira, C, Mahabee-Gittens, M, Pérez-Ríos, M. Dimensions and domains to assess secondhand tobacco smoke exposure: insights from a Delphi study. Gaceta Sanitaria. 2025; 39DOI:10.1016/j.gaceta.2025.102508. PMID:40554131. IF:1.500(Q3/7D).
01/06/2025
Drug Use Prevalence and Age of First Use in Sexual Minority Men Compared to General Population Men in Spain
Gonzalez-Recio, P, Granda, E, Donat, M, Palma, D, Moreno, S, Politi, J, Guerras, JM, Belza, MJ. Drug Use Prevalence and Age of First Use in Sexual Minority Men Compared to General Population Men in Spain. International Journal of Mental Health and Addiction. 2025; 23(3)DOI:10.1007/s11469-023-01232-6. PMID:. IF:2.500(Q2/4D).
01/06/2025
Effects of mosquito-proofing storm drains on adult and larvae mosquito abundance: Protocol of the IDAlErt storm drAin randomiSed controlled trial (IDEAS)
Treskova, M, Montalvo, T, Rocklöv, J, Hatfield, C, Bartumeus, F, Dasgupta, S, Encarnaçao, J, Lowe, R, Semenza, JC, Stiles, P, Noya, J, Valsecchi, A, Bärnighausen, T, Palmer, JRB, Bunker, A. Effects of mosquito-proofing storm drains on adult and larvae mosquito abundance: Protocol of the IDAlErt storm drAin randomiSed controlled trial (IDEAS). Methodsx. 2025; 14DOI:10.1016/j.mex.2024.103102. PMID:39850761. IF:(Q/D).
01/06/2025
Strengthening resilience to emerging vector-borne diseases in Europe: lessons learnt from countries facing endemic transmission
Chamley, GEC, Alcayna, T, Almuedo-Riera, A, Antoniou, C, Badolo, A, Bartumeus, F, Boodram, LL, Bueno-Mari, R, Codeco, C, Coelho, FC, Costa, F, Cox, H, Haddad, N, Ab Hamid, N, Kittayapong, P, Korukluog, G, Michaelakis, A, Maciel-de-Freitas, R, Montalvo, T, Munoz, J, Oliveras, SS, Palmer, JRB, Pizard, CJB, Ribeiro, GS, Lowe, R. Strengthening resilience to emerging vector-borne diseases in Europe: lessons learnt from countries facing endemic transmission. Lancet Regional Health-Europe. 2025; 53DOI:10.1016/j.lanepe.2025.101271. PMID:40247854. IF:13.000(Q1/1D).
01/06/2025
Emergency Healthcare Utilization and Unmet Care Needs in Chemsex Users: A Cross-Sectional Survey among Sexual Minority Men
Gonzalez-Recio, P, Moreno-García, S, Donat, M, Palma, D, Guerras, JM, Belza, MJ. Emergency Healthcare Utilization and Unmet Care Needs in Chemsex Users: A Cross-Sectional Survey among Sexual Minority Men. JOURNAL OF COMMUNITY HEALTH. 2025; 50(3)DOI:10.1007/s10900-024-01440-8. PMID:39833399. IF:2.200(Q2/5D).
01/06/2025
GOUT CHARACTERISTICS, COMORBIDITIES AND MANAGEMENT IN A LONG PRIMARY CARE DATABASE FROM CATALONIA: THE GOTAP STUDY
Pou, MA, Reyes, C, Martinez-Laguna, D, Tebe, C, Satorra, P, Dalbeth, N, Diaz-Torne, C. GOUT CHARACTERISTICS, COMORBIDITIES AND MANAGEMENT IN A LONG PRIMARY CARE DATABASE FROM CATALONIA: THE GOTAP STUDY. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B1407. PMID:. IF:20.600(Q1/1D).
01/06/2025
THE YOUNG, THE METABOLIC ANDTHE HYPERTENSIVE. A CLUSTER ANALYSIS OF GOUT CHARACTERISTICS AND COMORBIDITIES
Pou, MA, Reyes, C, Martinez-Laguna, D, Satorra, P, Tebe, C, Dalbeth, N, Diaz-Torne, C. THE YOUNG, THE METABOLIC ANDTHE HYPERTENSIVE. A CLUSTER ANALYSIS OF GOUT CHARACTERISTICS AND COMORBIDITIES. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B2148. PMID:. IF:20.600(Q1/1D).
01/06/2025
Perspectives of clinicians and screening candidates on shared decision-making in prostate cancer screening with the prostate-specific antigen (PSA) test: a qualitative study (PROSHADE study)
Sanchis, MJ, Guilabert, M, Parker, LA, Caballero-Romeu, JP, Chilet-Rosell, E, Gómez-Pérez, L, Alonso-Coello, P, Cebrián, A, López-Garrigós, M, Moral, I, Ronda-Pérez, E, Canelo-Aybar, C, Hernández-Aguado, I, Párraga, I, Del Campo-Giménez, M, Lumbreras, B. Perspectives of clinicians and screening candidates on shared decision-making in prostate cancer screening with the prostate-specific antigen (PSA) test: a qualitative study (PROSHADE study). Bmj Evidence-Based Medicine. 2025; 30(3)DOI:10.1136/bmjebm-2024-113113. PMID:39797674. IF:7.600(Q1/1D).